Subscribe

CareRx Corporation (CRRX.TO)

CAD3.37 -0.01 (-0.30%)
CA TSX Healthcare Medical - Care Facilities
Address 20 Eglinton Avenue West M4R 1K8
Toronto, ON, CA
CEO Puneet Khanna
Website carerx.ca
IPO 2008-02-13
ISIN CA14173C1059

Explore sections of this company profile

Also trades on Other OTC · CHHHF (USD) Toronto Stock Exchange · CRRX.TO (CAD)
Description

CareRx Corporation, operating with its subsidiaries, specializes in delivering tailored pharmaceutical services to Canada's senior demographic. The company manages a vast network of medication dispensing facilities, which are responsible for providing chronic prescriptions and a variety of other advanced clinical pharmacy solutions. Currently, it caters to approximately 50,000 individuals residing in roughly 900 distinct senior and communal living environments, including extended care residences, retirement communities, supportive living facilities, and group homes. Founded in 2001 and based in Toronto, Canada, the corporation rebranded as CareRx Corporation in June 2020, having formerly been known as Centric Health Corporation.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
CAD3.37 -0.01 (-0.30%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
34.7K
Beta
0.62
Float Shares
55.95M
Free Float %
88.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.57% -4.63% -8.38% -8.62% +0.86% -8.38% +25.90% +54.19% -41.76% -32.69% -57.32%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
3.37
DCF (Unlevered) 18.98 +463.1%
DCF (Levered) 16.62 +393.2%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 86% Bullish
Rating 2026-05 Change
Strong Buy 2 0
Buy 4 +1
Hold 1 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.16
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Medical - Care Facilities: +10.2%
    +1.0% Q1'26: +4.9% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +648.9% ★ Q1'26: +417.1% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +10.7% ★ Q1'26: +6.4% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +3.2% Q1'26: +3.7% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +6.9% ★ Q1'26: +5.3% (vs Q1'25)
  • ✗
    Share dilution Medical - Care Facilities: +0.0%
    +7.0% Q1'26: -0.8% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    2.58× Q1'26: 2.45× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.62) × ERP
WACC = 75% × Ke + 25% × Kd (8.8%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 18.76 Current price: 3.37
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
6 Rev. Ana.
3 EPS Ana. 		Dec 2027
5 Rev. Ana.
3 EPS Ana. 		Dec 2028
3 Rev. Ana.
2 EPS Ana.
Revenue
162.42M
est: 350.79M (-53.7%)
167.36M
est: 172.29M (-2.9%)
168.97M
est: 172.12M (-1.8%)
123.74M
est: 166.45M (-25.7%)
124.63M
est: 125.91M (-1.0%)
162.20M
est: 167.31M (-3.1%)
262.63M
est: 257.50M (+2.0%)
381.73M
est: 381.47M (+0.1%)
370.75M
est: 366.55M (+1.1%)
366.71M
est: 365.09M (+0.4%)
370.24M
est: 369.42M (+0.2%)
384.98M
380.06M – 393.66M
+4.2% YoY
403.44M
386.96M – 417.25M
+4.8% YoY
417.66M
416.13M – 419.19M
+3.5% YoY
EBITDA
13.55M
est: 13.33M (+1.6%)
3.12M
est: 6.55M (-52.3%)
11.96M
est: 6.54M (+82.8%)
-19.26M
est: 6.33M (-404.5%)
-5.82M
est: 4.78M (-221.6%)
4.15M
est: 6.36M (-34.7%)
9.01M
est: 9.78M (-7.9%)
-610.0K
est: 14.50M (-104.2%)
24.65M
est: 57.26M (-56.9%)
23.90M
est: 57.03M (-58.1%)
30.22M
est: 57.71M (-47.6%)
60.14M
59.37M – 61.49M
+4.2% YoY
63.02M
60.45M – 65.18M
+4.8% YoY
65.24M
65.00M – 65.48M
+3.5% YoY
EBIT
-14.21M
est: -6.88M (-106.6%)
-8.52M
est: -3.38M (-152.3%)
3.01M
est: -3.37M (+189.3%)
-29.61M
est: -3.26M (-807.3%)
-15.91M
est: -2.47M (-544.6%)
-16.88M
est: -3.28M (-414.5%)
-6.38M
est: -5.05M (-26.4%)
-20.68M
est: -7.48M (-176.4%)
4.68M
est: 42.13M (-88.9%)
4.71M
est: 41.96M (-88.8%)
11.88M
est: 42.46M (-72.0%)
44.25M
43.68M – 45.24M
+4.2% YoY
46.37M
44.47M – 47.96M
+4.8% YoY
48.00M
47.83M – 48.18M
+3.5% YoY
Net Income
46.08M
est: -178.35M (+125.8%)
-19.68M
est: -103.64M (+81.0%)
1.85M
est: 2.71M (-31.9%)
-31.09M
est: -6.03M (-416.0%)
-45.68M
est: -30.13M (-51.6%)
-18.18M
est: -43.28M (+58.0%)
-22.73M
est: -28.70M (+20.8%)
-34.35M
est: -41.90M (+18.0%)
-5.41M
est: -7.68M (+29.6%)
-4.50M
est: -866.8K (-419.3%)
26.13M
est: 4.39M (+495.2%)
10.23M
8.89M – 11.56M
+133.0% YoY
7.94M
7.40M – 24.07M
-22.4% YoY
19.99M
17.64M – 22.34M
+151.8% YoY
SGA
26.77M
est: 67.56M (-60.4%)
24.12M
est: 33.18M (-27.3%)
24.78M
est: 33.15M (-25.2%)
20.45M
est: 32.06M (-36.2%)
19.07M
est: 24.25M (-21.4%)
20.68M
est: 32.22M (-35.8%)
70.52M
est: 49.59M (+42.2%)
102.55M
est: 73.47M (+39.6%)
77.50M
est: 77.24M (+0.3%)
32.75M
est: 76.93M (-57.4%)
80.75M
est: 77.84M (+3.7%)
81.12M
80.09M – 82.95M
+4.2% YoY
85.01M
81.54M – 87.92M
+4.8% YoY
88.01M
87.69M – 88.33M
+3.5% YoY
EPS
5.80
est: -2.96 (+295.9%)
-2.39
est: -1.72 (-39.0%)
0.20
est: 0.05 (+344.4%)
-3.05
est: -0.10 (-2,950.0%)
-4.16
est: -0.50 (-732.0%)
-0.90
est: -0.72 (-25.3%)
-0.65
est: -0.48 (-36.5%)
-0.72
est: -0.70 (-3.3%)
-0.09
est: -0.12 (+20.8%)
-0.07
est: -0.01 (-456.3%)
0.42
est: 0.07 (+517.6%)
0.16
0.14 – 0.18
+133.2% YoY
0.24
0.11 – 0.37
+53.9% YoY
0.31
0.27 – 0.35
+27.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-07 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-05-06 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-05-05 A 4/5 5/5 5/5 5/5 1/5 4/5 3/5
2026-05-04 A 4/5 5/5 5/5 5/5 1/5 4/5 3/5
2026-05-01 A 4/5 5/5 5/5 5/5 1/5 4/5 3/5
2026-04-30 A 4/5 5/5 5/5 5/5 1/5 4/5 3/5
2026-04-29 A 4/5 5/5 5/5 5/5 1/5 4/5 3/5
2026-04-28 A 4/5 5/5 5/5 5/5 1/5 4/5 3/5
2026-04-27 A 4/5 5/5 5/5 5/5 1/5 4/5 3/5
2026-04-24 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-04-23 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-04-22 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-04-21 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-04-20 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-04-17 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5
2026-04-16 A 4/5 5/5 5/5 5/5 1/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
24.69M
OE per share TTM
0.38
Owner's Yield
11.06%
Maintenance CapEx ratio
34.20%
Maint CapEx / Avg PPE
14.5%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Dimensional - International Core Equity 2 ETF DFIC 0.00% 35.3K 0.22%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
8.4K
Shares Outstanding
62.92M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Puneet Khanna Chief Executive Officer, President & Director 817.1K male
Suzanne Brand Chief Financial Officer 438.7K female
Adrianne Sullivan Campeau Chief Employee & Customer Experience Officer 401.7K female
Travis Featherstone Chief Clinical Officer 360.4K male
Alpinder Grewal Chief Operating Officer 355.0K male
Erwin Van Hout Senior Vice President of Information Technology — male
Davide Pernarella Vice President of Business Planning & Analysis — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities